CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
Real-World Evidence And Wearables Are Reshaping Trial Tech
ISPOR’s Rob Abbott on why RWE moved to number two in the 2026-2027 HEOR Trends Report, and what wearables, data fragmentation, and HARPER+ mean for clinical platforms.
-
HEOR, AI, And The Future Of Clinical Trial Technology
ISPOR CEO Rob Abbott on why HEOR must be in the room when clinical trial tech is built, and what ISPOR’s latest Top 10 HEOR Trends Report means for ClinOps.
ECOA RESOURCES
-
Learn why sponsors should implement an integrated data monitoring plan and technology solution to ensure data integrity, meet evolving regulatory requirements, and improve trial outcomes.
-
Maximize efficiency today with a cloud-based user-friendly platform that seamlessly adapts to the future of phase 1-3 trials. Watch to see how Zelta can help.
-
Clinical trials are essential to advancing medicine, yet they carry significant environmental costs. Inefficiencies not only drive emissions but also risk drug shortages and trial delays, and clinical technology solutions offer a pathway to more sustainable research.
ECONSENT RESOURCES
-
Scott Askin paints the picture of why Novartis, determined to improve the patient experience, has begun to deploy eConsent, and what they’ve learned along the way.
-
Learn how eConsent digitalizes the trial participant consent process through increasingly simplified models designed to improve comprehension and boost engagement.
-
Clinical trials are essential to advancing medicine, yet they carry significant environmental costs. Inefficiencies not only drive emissions but also risk drug shortages and trial delays, and clinical technology solutions offer a pathway to more sustainable research.
EPRO RESOURCES
-
Maximize efficiency today with a cloud-based user-friendly platform that seamlessly adapts to the future of phase 1-3 trials. Watch to see how Zelta can help.
-
Learn how eConsent digitalizes the trial participant consent process through increasingly simplified models designed to improve comprehension and boost engagement.
-
Willie Muehlhausen, Co-CEO and Founder of Safira Clinical Research, and Tim Davis, VP of Strategy at MyVeeva for Patients, discuss how ePRO delivery needs to change to better serve modern trials.